➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Medtronic
Merck
Colorcon
Mallinckrodt
Express Scripts

Last Updated: September 21, 2021

DrugPatentWatch Database Preview

ZECUITY Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

When do Zecuity patents expire, and what generic alternatives are available?

Zecuity is a drug marketed by Teva Branded Pharm and is included in one NDA. There are ten patents protecting this drug.

This drug has one hundred and seven patent family members in sixteen countries.

The generic ingredient in ZECUITY is sumatriptan succinate. There are twenty-four drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the sumatriptan succinate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Zecuity

A generic version of ZECUITY was approved as sumatriptan succinate by WEST-WARD PHARMS INT on February 6th, 2009.

  Try it Free

Summary for ZECUITY
Drug patent expirations by year for ZECUITY
Recent Clinical Trials for ZECUITY

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
NuPathe Inc.Phase 1

See all ZECUITY clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for ZECUITY

US Patents and Regulatory Information for ZECUITY

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Branded Pharm ZECUITY sumatriptan succinate SYSTEM;IONTOPHORESIS 202278-001 Jan 17, 2013 DISCN Yes No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Teva Branded Pharm ZECUITY sumatriptan succinate SYSTEM;IONTOPHORESIS 202278-001 Jan 17, 2013 DISCN Yes No ⤷  Try it Free ⤷  Try it Free Y ⤷  Try it Free
Teva Branded Pharm ZECUITY sumatriptan succinate SYSTEM;IONTOPHORESIS 202278-001 Jan 17, 2013 DISCN Yes No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Teva Branded Pharm ZECUITY sumatriptan succinate SYSTEM;IONTOPHORESIS 202278-001 Jan 17, 2013 DISCN Yes No ⤷  Try it Free ⤷  Try it Free Y ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Medtronic
Merck
Colorcon
Mallinckrodt
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.